Published September 22, 2021 | Version LFIA, diphtheria laboratory diagnosis
Conference paper Open

Re-entering the diphtheria laboratory diagnosis

  • 1. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russian Federation
  • 2. Bavarian Health and Food Safety Authority, National Consiliary Laboratory on Diphtheria, Oberschleißheim, Germany
  • 3. Bavarian Health and Food Safety Authority, Public Health Microbiology, Oberschleißheim, Germany

Description

Toxigenic C. diphtheriae pose a serious threat to unvaccinated and immunocompromised individuals, whose numbers have recently increased in Europe. The International system of quality control revealed the poor state of laboratory diagnosis of diphtheria in EU countries, which means Europe is not well prepared for the possible outbreaks. This is mostly due to the absence of simple, standard and reliable laboratory diagnostic methods. The main element in the diphtheria diagnostic scheme is a detection of the bacterial toxin (DT). The common method for detecting the production of DT by corynebacteria, gel immunoprecipitation or Elek test developed in 1949, is vulnerable, time consuming and laborious. PCR for DT gene detection is inaccurate as non-toxigenic C. diphtheriae and C. ulcerans strains carrying the mutated toxin gene circulate worldwide. Rapid immunochemical test (LFIA) for the detection of diphtheria toxin was developed and evaluated.

Notes

9th Bavarian Congress for the Public Health Service. On-line Kongress, September 22nd to 24th, 2021. Congress proceedings. Journal of Environmental and Occupational Health Sciences, 2021, Volume 26, No 4, P. 166-167.

Files

uha_2021_04_lgl_red_nd.pdf

Files (6.2 MB)

Name Size Download all
md5:38f961bcc2ae1c76d8eb610660627011
6.2 MB Preview Download

Additional details

Funding

European Commission
DIFTERIA - Development of a simple and rapid assay for early diphtheria diagnosis. 843405